Agenda Overview
Wednesday, November 15, 2000 Thursday, November 16 and Friday, November 17, 2000 Featuring:
Preconference Symposium
National Congress
 |
Clement
Bezold, Ph.D. President Institute for Alternative Futures Alexandria, VA |
 |
Samuel
Broder, M.D. Executive Vice President and Chief Medical Officer Celera Genomics Rockville, MD |
 |
Francis
Collins, MD, Ph.D. Director National Human Genome Research Institute Bethesda, MA |
 |
Raymond
Gilmartin Chairman, President and CEO Merck & Co., Inc. Whitehouse Station, NJ |
 |
William
A. Haseltine, Ph.D. Chairman and CEO Human Genome Sciences Rockville, MD |
 |
Charles
N. (Chip) Kahn III President The Health Insurance Association of America Washington, D.C. |
 |
Edward
Penhoek, Ph.D. Dean, School of Public Health University of California at Berkeley Berkeley, CA |
 |
Robert
D. Reischauer, Ph.D. Senior Fellow The Brookings Institute Washington, DC |
 |
Barrett
Toan President and Chief Executive Officer Express Scripts, Inc. Maryland Heights, MO |
 |
Gail
Wilensky, Ph.D. Chair, The Medicare Payment Advisory Bethesda, MD |
 |
Karen
Williams, Ph.D. President, National Pharmaceutical Council Reston, VA |
 |
Janet
Woodcock, MD Director, Center for Drug Evaluation and Research Food and Drug Administration Rockville, MD |